Review of various herbal supplements as complementary treatments for oral cancer

Journal of Dietary Supplements

Volume 13, Issue 5, 2 September 2016, Pages 538-550

Review

Godsey, J. , 

Grundmann, O.

 

Department of Medicinal Chemistry, College of Pharmacy, University of Florida, 1345 Center Drive, Gainesville, FL, United States 

View references (31)

Abstract

In the United States, nearly 44,000 people are diagnosed with oral or pharyngeal cancer annually. The life expectancy for those who are diagnosed have a survival rate of 57% after five years. Among them, oral cancer can be classified as benign or malignant tumors and is diagnosed at several stages in the development: premalignant conditions, premalignant lesions, and malignant cancer. The early signs of oral cancer often go unnoticed by the individual and are often discovered during routine dental examinations. Early detection and treatment may help to increase patient survival rates. The most widely used treatments for oral cancer include surgery, radiation, and chemotherapy - alone or in combination. Preclinical and clinical evidence for the use of green tea, raspberry, asparagus, and cannabis extracts is discussed in this review. Diet changes, supplementation with antioxidants, high-dose vitamin C therapy, and cannabinoid use have been suggested to decrease cancer cell replication and increase chance of remission. Early detection and lifestyle changes, including the use of dietary supplements in at-risk populations, are critical steps in preventing and successfully treating oral cancer. The main evidence for supplement use is currently in cancer prevention rather than treatment. Further research, determination, and mechanism of action for bioactive compounds such as epigallocatechin, epicatechin-3-gallate, and Bowman-Birk inhibitor concentrate, through in vitro, in vivo, and clinical trials need to be completed to support the use of natural products and their effectiveness in preventative care and supporting therapeutic approaches. © 2016 Taylor & Francis Group, LLC.

Author keywords

antioxidant; herbal supplements; oral cancer

ISSN: 19390211Source Type: Journal Original language: English

DOI: 10.3109/19390211.2015.1122693Document Type: Review

Publisher: Taylor and Francis Ltd

References (31)

View in search results format

• Page
 
• • Export |
  • Print |
  • E-mail |
  • Create bibliography

• 
  1

  Anderson, K.S., Dahlstrom, K.R., Cheng, J.N., Alam, R., Li, G., Wei, Q., Gross, N.D., (...), Sturgis, E.M.

  HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status
  (2015) Oral Oncology, 51 (7), pp. 662-667. Cited 5 times.
  www.elsevier.com/inca/publications/store/1/0/5
  doi: 10.1016/j.oraloncology.2015.04.011
  

  • View at Publisher
• 
  2

  Ang, K.K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D.I., Nguyen-Tân, P.F., Westra, W.H., (...), Gillison, M.L.

  Human papillomavirus and survival of patients with oropharyngeal cancer
  (2010) New England Journal of Medicine, 363 (1), pp. 24-35. Cited 1520 times.
  http://content.nejm.org/cgi/reprint/363/1/24.pdf
  doi: 10.1056/NEJMoa0912217
  

  • View at Publisher
• 
  3

  Armstrong, W.B., Kennedy, A.R., Wan, X.S., Taylor, T.H., Nguyen, Q.A., Jensen, J., Thompson, W., (...), Meyskens F.L., Jr.

  Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial
  (2000) Clinical Cancer Research, 6 (12), pp. 4684-4691. Cited 99 times.
  

  • View at Publisher
• 
  4

  Armstrong, W.B., Wan, X.S., Kennedy, A.R., Taylor, T.H., Meyskens Jr., F.L.

  Development of the Bowman-Birk Inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk Inhibitor concentrate treatment
  (2003) Laryngoscope, 113 (10), pp. 1687-1702. Cited 33 times.
  doi: 10.1097/00005537-200310000-00007
  

  • View at Publisher
• 
  5

  Bsoul, S.A., Huber, M.A., Terezhalmy, G.T.

  Squamous cell carcinoma of the oral tissues: A comprehensive review for oral healthcare providers
  (2005) Journal of Contemporary Dental Practice, 6 (4), pp. 1-16. Cited 38 times.
  http://www.thejcdp.com/issue024/bsoul/bsoul.pdf
  
• 
  6

  Day, G.L., Blot, W.J., Austin, D.F., Bernstein, L., Greenberg, R.S., Preston-martin, S., Schoenberg, J.B., (...), Fraumeni, J.F.

  Racial differences in risk of oral and pharyngeal cancer: Alcohol, tobacco, and other determinants
  (1993) Journal of the National Cancer Institute, 85 (6), pp. 465-473. Cited 145 times.
  doi: 10.1093/jnci/85.6.465
  

  • View at Publisher
• 
  7

  Desantis, C.E., Lin, C.C., Mariotto, A.B., Siegel, R.L., Stein, K.D., Kramer, J.L., Alteri, R., (...), Jemal, A.

  Cancer treatment and survivorship statistics, 2014
  (2014) CA Cancer Journal for Clinicians, 64 (4), pp. 252-271. Cited 482 times.
  http://onlinelibrary.wiley.com/journal/10.3322/(ISSN)1542-4863
  doi: 10.3322/caac.21235
  

  • View at Publisher
• 
  8

  Ding, Y., Yao, H., Yao, Y., Fai, L.Y., Zhang, Z.

  Protection of dietary polyphenols against oral cancer
  (2013) Nutrients, 5 (6), pp. 2173-2191. Cited 12 times.
  http://www.mdpi.com/2072-6643/5/6/2173/pdf
  doi: 10.3390/nu5062173
  

  • View at Publisher
• 
  9

  Edefonti, V., Hashibe, M., Parpinel, M., Turati, F., Serraino, D., Matsuo, K., Olshan, A.F., (...), Decarli, A.

  Natural vitamin C intake and the risk of head and neck cancer: A pooled analysis in the International Head and Neck Cancer Epidemiology Consortium
  (2015) International Journal of Cancer, 137 (2), pp. 448-462. Cited 3 times.
  http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0215
  doi: 10.1002/ijc.29388
  

  • View at Publisher
• 
  10

  Fang, J.

  Bioavailability of anthocyanins
  (2014) Drug Metabolism Reviews, 46 (4), pp. 508-520. Cited 20 times.
  http://informahealthcare.com/loi/dmr
  doi: 10.3109/03602532.2014.978080
  

  • View at Publisher
• 
  11

  Gullett, N.P., Ruhul Amin, A.R.M., Bayraktar, S., Pezzuto, J.M., Shin, D.M., Khuri, F.R., Aggarwal, B.B., (...), Kucuk, O.

  Cancer prevention with natural compounds
  (2010) Seminars in Oncology, 37 (3), pp. 258-281. Cited 201 times.
  http://www.elsevier.com/inca/publications/store/6/2/3/3/7/8/index.htt
  doi: 10.1053/j.seminoncol.2010.06.014
  

  • View at Publisher
• 
  12

  Gupta, S., Singh, R., Gupta, O.P., Tripathi, A.
  Prevalence of oral cancer and pre-cancerous lesions and the association with numerous risk factors in North India: A hospital based study
  (2014) Natl J Maxillofac Surg, 5 (2), pp. 142-148.
  

  •  
• 
  13

  Hoffer, L.J., Robitaille, L., Zakarian, R., Melnychuk, D., Kavan, P., Agulnik, J., Cohen, V., (...), Miller, W.H.

  High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: A phase I-II clinical trial
  (2015) PLoS ONE, 10 (4), art. no. e0120228. Cited 3 times.
  http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0120228&representation=PDF
  doi: 10.1371/journal.pone.0120228
  

  • View at Publisher
• 
  14

  Madani, A.H., Dikshit, M., Bhaduri, D., Aghamolaei, T., Moosavy, S.H., Azarpaykan, A.
  Interaction of alcohol use and specific types of smoking on the development of oral cancer
  (2014) Int J High Risk Behav Addict, 3 (1), p. e12120. Cited 6 times.
  

  •  
• 
  15

  Mallery, S.R., Budendorf, D.E., Larsen, M.P., Pei, P., Tong, M., Holpuch, A.S., Larsen, P.E., (...), Liu, Z.

  Effects of human oral mucosal tissue, saliva, and oral microflora on intraoral metabolism and bioactivation of black raspberry anthocyanins
  (2011) Cancer Prevention Research, 4 (8), pp. 1209-1221. Cited 22 times.
  http://cancerpreventionresearch.aacrjournals.org/content/4/8/1209.full.pdf+html
  doi: 10.1158/1940-6207.CAPR-11-0040
  

  • View at Publisher
• 
  16

  Mallery, S.R., Stoner, G.D., Larsen, P.E., Fields, H.W., Rodrigo, K.A., Schwartz, S.J., Tian, Q., (...), Mumper, R.J.

  Formulation and in-vitro and in-vivo evaluation of a mucoadhesive gel containing freeze dried black raspberries: Implications for oral cancer chemoprevention
  (2007) Pharmaceutical Research, 24 (4), pp. 728-737. Cited 30 times.
  doi: 10.1007/s11095-006-9192-1
  

  • View at Publisher
• 
  17

  Marks, M.A., Chaturvedi, A.K., Kelsey, K., Straif, K., Berthiller, J., Schwartz, S.M., Smith, E., (...), D'Souza, G.

  Association of marijuana smoking with oropharyngeal and oral tongue cancers: Pooled analysis from the INHANCE consortium
  (2014) Cancer Epidemiology Biomarkers and Prevention, 23 (1), pp. 160-171. Cited 9 times.
  http://cebp.aacrjournals.org/content/23/1/160.full.pdf+html
  doi: 10.1158/1055-9965.EPI-13-0181
  

  • View at Publisher
• 
  18

  Mayne, S.T., Cartmel, B., Lin, H., Zheng, T., Goodwin Jr., W.J.

  Low Plasma Lycopene Concentration is Associated with Increased Mortality in a Cohort of Patients with Prior Oral, Pharynx or Larynx Cancers
  (2004) Journal of the American College of Nutrition, 23 (1), pp. 34-42. Cited 27 times.
  

  • View at Publisher
• 
  19

  Meyskens Jr., F.L.

  Development of Bowman-Birk Inhibitor for chemoprevention of oral head and neck cancer
  (2001) Annals of the New York Academy of Sciences, 952, pp. 116-123. Cited 30 times.
  

  • View at Publisher
• 
  20

  Mitra, S.K., Prakash, N.S., Sundaram, R.

  Shatavarins (containing Shatavarin IV) with anticancer activity from the roots of Asparagus racemosus
  (2012) Indian Journal of Pharmacology, 44 (6), pp. 732-736. Cited 7 times.
  doi: 10.4103/0253-7613.103273
  

  • View at Publisher
• 
  21

  Putchala, M.C., Ramani, P., Sherlin, H.J., Premkumar, P., Natesan, A.

  Ascorbic acid and its pro-oxidant activity as a therapy for tumours of oral cavity-A systematic review
  (2013) Archives of Oral Biology, 58 (6), pp. 563-574. Cited 15 times.
  doi: 10.1016/j.archoralbio.2013.01.016
  

  • View at Publisher
• 
  22

  Ramshankar, V., Krishnamurthy, A.

  Chemoprevention of oral cancer: Green tea experience
  (2014) Journal of Natural Science, Biology and Medicine, 5 (1), pp. 3-7. Cited 10 times.
  doi: 10.4103/0976-9668.127272
  

  • View at Publisher
• 
  23

  Schalk, A.M., Lavie, A.

  Structural and kinetic characterization of guinea pig l-asparaginase type III
  (2014) Biochemistry, 53 (14), pp. 2318-2328. Cited 4 times.
  http://pubs.acs.org/journal/bichaw
  doi: 10.1021/bi401692v
  

  • View at Publisher
• 
  24

  Seeman, P.

  Discovery of why acute lymphoblastic leukaemia cells are killed by asparaginase: Adventures of a young post-doctoral student, Bertha K Madras
  (2014) Journal of Medical Biography, 22 (2), pp. 90-92. Cited 2 times.
  http://www.jmb.rsmjournals.com
  doi: 10.1177/0967772013498541
  

  • View at Publisher
• 
  25

  Shao, Y., Chin, C.-K., Ho, C.-T., Ma, W., Garrison, S.A., Huang, M.-T.

  Anti-tumor activity of the crude saponins obtained from asparagus
  (1996) Cancer Letters, 104 (1), pp. 31-36. Cited 64 times.
  doi: 10.1016/0304-3835(96)04233-4
  

  • View at Publisher
• 
  26

  Shrivastava, A., Khan, A.A., Khurshid, M., Kalam, M.A., Jain, S.K., Singhal, P.K.
  Recent developments in l-Asparaginase discovery and its potential as anticancer agent
  (2015) Crit Rev Oncol Hematol. Cited 4 times.
  

  •  
• 
  27

  Singh, M., Krishanappa, R., Bagewadi, A., Keluskar, V.

  Efficacy of oral lycopene in the treatment of oral leukoplakia
  (2004) Oral Oncology, 40 (6), pp. 591-596. Cited 40 times.
  doi: 10.1016/j.oraloncology.2003.12.011
  

  • View at Publisher
• 
  28

  Tsao, A.S., Liu, D., Martin, J., Tang, X.-M., Lee, J.J., El-Naggar, A.K., Wistuba, I., (...), Papadimitrakopoulou, V.

  Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions
  (2009) Cancer Prevention Research, 2 (11), pp. 931-941. Cited 102 times.
  http://cancerpreventionresearch.aacrjournals.org/content/2/11/931.full.pdf+html
  doi: 10.1158/1940-6207.CAPR-09-0121
  

  • View at Publisher
• 
  29

  Wahlqvist, M.L., Dalais, F.S.

  Phytoestrogens: Emerging multifaceted plant compounds
  (1997) Medical Journal of Australia, 167 (3), pp. 119-120. Cited 16 times.
  
• 
  30

  Weatherspoon, D.J., Chattopadhyay, A., Boroumand, S., Garcia, I.

  Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000-2010
  (2015) Cancer Epidemiology, 39 (4), pp. 497-504. Cited 2 times.
  http://www.elsevier.com
  doi: 10.1016/j.canep.2015.04.007
  

  • View at Publisher
• 
  31

  Whyte, D.A., Al-Hammadi, S., Balhaj, G., Brown, O.M., Penefsky, H.S., Souid, A.-K.

  Cannabinoids inhibit cellular respiration of human oral cancer cells
  (2010) Pharmacology, 85 (6), pp. 328-335. Cited 14 times.
  doi: 10.1159/000312686
  

  • View at Publisher

  Godsey, J.; Department of Medicinal Chemistry, College of Pharmacy, University of Florida, 1345 Center Drive, United States; email:jessielgodsey@gmail.com
© Copyright 2016 Elsevier B.V., All rights reserved.